javeri fiscal logo
Home SiteMap ContactUs
javeri fiscal services Ltd
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO > PEER COMPARISON
Peer Comparison      
Lupin Ltd.
Peer CompaniesPrice(Rs)Chg(Rs) Chg(%)EPS(Rs.)TTM P/EVolume(000's)1Year Return(%)Divinded YieldBook Value
Abbott India 28710.6 435.35 gain 1.54 730.39 39.32 1791-15.7 2.28 2234.2
NGL Fine-Chem 3155 147.85 gain 4.92 67.39 46.75 162140.89 0.06 452.6
Venus Remedies 1799 75 gain 4.35 84.64 21.25 8866233.06 0.56 441.01
Ajanta Pharma 3540.7 71.5 gain 2.06 75.78 46.83 1079127.54 0.79 337.89
CORONA Remedies 2097 54.65 gain 2.68 30.22 69.38 2485  0.48 121.97
Acutaas Chemicals 3695.4 39.15 gain 1.07 44.73 82.56 14654210.46 0.07 160.19
Bharat Parenterals 1455 38.6 gain 2.73 23.24 62.6 1895-6.13 0.07 561.27
Laurus Labs 1596.8 37.6 gain 2.41 13.71 116.37 7789792.52 0.13 96.82
Sanofi Cons. Health 4557.4 31.7 gain 0.7 111.98 40.7 195-9.72 1.65 166.96
Emcure Pharma 1892 31.3 gain 1.68 38.64 48.81 1045139.37 0.19 158.99
Supriya Lifescience 861.9 25.2 gain 3.01 25.98 33.21 675923.54 0.12 123.84
Torrent Pharma 5023 19.75 gain 0.39 57.62 87.26 552042.53 0.76 249.72
Akums Drugs & Pharma 695.4 19.35 gain 2.86 7.09 98.08 563927.62 0.43 158.56
Alivus Life Sciences 1150.25 16.55 gain 1.46 45.99 25.01 45718.92 0.43 229.11
Aurobindo Pharma 1576.5 15.95 gain 1.02 41.97 37.52 5300138.48 0.25 353.55
Albert David 704.95 14.6 gain 2.11 -2.62 0 255-23.3 0.71 686.04
Astrazeneca Pharma 8077.05 13.45 gain 0.17 75.01 107.68 254-11.52 0.45 346.51
Alkem Laboratories 5668.5 11.95 gain 0.21 182.76 31.04 103713.41 0.93 1030.68
Accretion Nutraveda 278 10.5 gain 3.93 7 39.71 2000  0 109.83
Natco Pharma 961 10.45 gain 1.1 71.55 13.43 15478-5.29 0.52 409.72
Page 1 of 9 Prev || Next
kyc form Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Scores| Policies of JFSL
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE| Rights and obligation| SARAL Form
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.